GleamWall
中文EN

ZTS Zoetis Inc.

Pharmaceutical Preparations · NYSE · SEC CIK 1555280 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.0%
TTM net income YoY-5.5%
TTM EPS YoY0.7%
Revenue 3-yr CAGR4.3%
Net income 3-yr CAGR2.9%

Margins

Gross margin71.4%
Operating margin—
Net margin26.1%
FCF margin24.0%
EBITDA margin—

Returns

ROE57.1%
ROA16.4%
ROIC (approx.)—
Asset turnover0.63x

Leverage & solvency

Liabilities / assets78.1%
Debt / equity2.74x
Current ratio2.35x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.12x
Accruals ratio-1.9%
Payout ratio—
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$9.47B$9.26B
Cost of revenue$2.67B$2.72B
Gross profit$6.80B$6.54B
R&D expense$698.00M$686.00M
SG&A expense$2.38B$2.32B
Interest expense$222.00M$225.00M
Pretax income$3.36B$3.13B
Income tax$687.00M$637.00M
Net income$2.67B$2.49B
EPS (basic)6.035.47
EPS (diluted)6.025.47
Dividends declared per share2.031.80
Weighted avg. shares (diluted)443.83M454.85M
Balance sheet
Cash & equivalents$2.45B$2.11B
Short-term investments$0—
Receivables$1.41B$1.32B
Inventory$2.46B$2.31B
Current assets$6.77B$5.99B
PP&E, net$3.69B$3.39B
Goodwill$2.77B$2.72B
Intangibles$998.00M$1.13B
Total assets$15.49B$14.24B
Current liabilities$2.17B$3.41B
Short-term debt$0$1.35B
Long-term debt$9.04B$5.22B
Total debt$9.04B$6.57B
Total liabilities$12.07B$9.47B
Shareholders' equity$3.42B$4.77B
Net debt$6.59B$4.46B
Shares outstanding424.93M448.47M
Cash flow statement
Operating cash flow$2.90B$2.95B
Capital expenditure$621.00M$655.00M
Free cash flow$2.28B$2.30B
Investing cash flow-$748.00M-$315.00M
Financing cash flow-$1.87B-$2.66B
Depreciation & amortization$487.00M$497.00M
Stock-based compensation$83.00M$74.00M
Share buybacks$3.23B$1.86B

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.